glp-1 inflammatory bowel disease for Crohn's Disease: Current Evidence and Treatment Options GLP-1 IBD obesity "inflammatory bowel

In this blog, well take a closer look at the science behind these medications how they work, what the research says, and their risks and benefits

Aim for adequate fluid intake throughout the day, and consider low-sugar or sugar-free electrolyte-containing beverages if you have persistent diarrhea or vomiting, especially if you have diabetes

Over one-third of people interested in losing weight say the medications are too costly

doi: 10.1038/nrn2647

An investment thesis for novel obesity therapeutics An investment thesis for novel obesity therapeutics Therapeutic strategies with novel mechanisms of action, rather than countless me-too incretin-based drugs, could lead to synergistic combinations and more durable treatmentsas in traditional diabetes and heart failure management

It is not even in the same category